CRO Pharmaceutical Product Development (PPD) has formalized relationships with eight investigator sites to create a pediatric investigator network (PIN) as part of efforts to speed trial startups, more predictably enroll patients and offer higher quality data to clients.
The world’s second-largest central lab services company is now operational, with Quintiles and Quest Diagnostics calling their new creation Q2 Solutions.
GSK’s HIV unit ViiV Healthcare and China-based Desano Pharmaceuticals have forged an agreement whereby Desano will manufacture the API of GSK’s HIV drug Tivicay (dolutegravir) in China.
UK firm Reach Separations is doubling its lab space as pharma companies call for more chromatography services.
In another setback for Alzheimer’s drug developers, European CRO/biotech Evotec and partner Roche have announced that their candidate did not meet its primary endpoint after 52 weeks treatment in a Phase IIb study.
Lonza will set up a dedicated manufacturing suite for Alexion, producer of the world’s most expensive drug Soliris.